Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDNew phase 2 data for amlitelimab show ...

The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

But the episode was a reminder that the king is 76 and continues to undergo treatment for an undisclosed form of cancer diagnosed more than a year ago. Advertisement Advertisement That reality has ...

Other symptoms may include: If symptoms are sudden and severe, people may need hospital treatment, such as intravenous antibiotics or surgery. A heart attack occurs when something blocks an artery ...

Treatment depends on the cause and can include simple at ... which can be serious or life-threatening. These include asthma, bronchiectasis, cystic fibrosis, and COPD. People who are more at risk for ...

Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...

A significant advancement in the treatment of bronchiectasis has emerged from a recent Phase 2 clinical trial. The study, published in The Lancet Respiratory Medicine, evaluates the efficacy and ...

This finding not only provides a new treatment option for patients with bronchiectasis but also lays a solid foundation for the development of more targeted therapies in the future. This study also ...